Download PDF
Thromb Haemost 2005; 93(02): 392-393
DOI: 10.1055/s-0037-1616250
Letters to the Editor
Schattauer GmbH

Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels

Massimo Franchini
1   Servizio di Immunoematologia e Trasfusione – Centro Emofilia, Azienda Ospedaliera di Verona, Verona
,
Dino Veneri
2   Dipartimento di Medicina Clinica e Sperimentale, Sezione di Ematologia, Università di Verona, Verona
,
Giuseppe Lippi
3   Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Biomediche e Morfologiche, Università di Verona, Verona, Italy
› Author Affiliations
Further Information

Publication History

Received 14 September 2004

Accepted after resubmission 25 November 2004

Publication Date:
14 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Simone JV, Abildgaard CF, Schulman I. Blood coagulation in thyroid dysfunction.. N Engl J Med 1965; 273: 1057-61.
    CrossrefPubMedGoogle Scholar
  • 2 Myrup B, Bregengård C, Faber J. Primary haemostasis and thyroid disease.. J Int Med 1995; 238: 59-63.
    CrossrefPubMedGoogle Scholar
  • 3 Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases.. Eur J Endocrinol 1997; 136: 1-7.
    CrossrefPubMedGoogle Scholar
  • 4 Michiels JJ, Budde U, van der Planken, van Vliet HHDM, Schoyens W, Berneman Z. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.. Best Pract Res Clin Haematol 2001; 14: 401-36.
    CrossrefPubMedGoogle Scholar
  • 5 Franchini M, de Gironcoli M, Lippi G. et al Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery.. Haemophilia 2002; 8: 142-4.
    CrossrefPubMedGoogle Scholar
  • 6 Surks MI, Ortiz E, Daniels GH. et al Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management.. JAMA 2004; 291: 228-38.
    CrossrefPubMedGoogle Scholar